NASDAQ:APLS
Apellis Pharmaceuticals, Inc.
- Stock
Last Close
38.72
30/08 20:00
Market Cap
4.54B
Beta: 1.22
Volume Today
592.31K
Avg: 1.91M
PE Ratio
−13.43
PFCF: −12.54
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 240.05K - | 68.68K 71.39% | 8.14M - | 51M 526.30% | 116.04M 127.53% | |||||||
average payables | 552.70K - | 1.61M 192.11% | 2.51M 55.61% | 3.11M 23.60% | 6.96M 124.11% | 9.31M 33.75% | 8.42M 9.55% | 12.69M 50.77% | 27.13M 113.70% | 37.43M 37.98% | ||
average receivables | 266.53K - | 232.93K 12.61% | 5.05M - | 8.91M 76.48% | 107.08M 1,101.17% | |||||||
book value per share | 0.25 - | 0.73 192.42% | 1.93 164.48% | 1.32 31.97% | 10.74 716.49% | 2.96 72.44% | 0.55 81.41% | 2.72 394.77% | 2.35 13.53% | 2.26 3.96% | ||
capex per share | -0.00 - | -0.03 - | -0.07 165.10% | -0.01 81.89% | -0.02 55.19% | |||||||
capex to depreciation | -3.02 - | -7.06 - | -8.51 20.48% | -0.74 91.31% | -1.02 38.63% | |||||||
capex to operating cash flow | 0.00 - | 0.01 - | 0.03 321.25% | 0.00 94.20% | 0.00 51.45% | |||||||
capex to revenue | -0.02 - | -0.02 23.40% | -0.02 21.94% | |||||||||
cash per share | 0.26 - | 0.75 186.30% | 1.99 164.29% | 1.37 30.94% | 12.66 821.45% | 3.24 74.41% | 5.66 74.55% | 11.68 106.44% | 8.30 28.93% | 7.34 11.53% | ||
days of inventory on hand | 1.14K - | 5.55K 385.59% | 913.04 83.55% | |||||||||
days payables outstanding | 26.34 - | 29.26 11.09% | 10.60 63.79% | 123.52 1,065.78% | 1.19K 860.90% | 2.42K 103.76% | 234.03 90.32% | |||||
days sales outstanding | 55.40 - | 37.39 32.50% | 205.72 450.14% | |||||||||
debt to assets | 0.14 - | 0.13 8.30% | 0.40 203.62% | 0.39 2.53% | 0.24 39.37% | 0.15 37.81% | 0.12 20.44% | |||||
debt to equity | 0.18 - | 0.17 5.18% | 4.59 2,630.65% | 1.85 59.75% | 1.06 42.70% | 0.66 37.30% | 0.48 27.92% | |||||
dividend yield | ||||||||||||
earnings yield | -0.02 - | -0.04 172.33% | -0.18 331.16% | -0.11 41.69% | -0.17 58.58% | -0.18 4.87% | -0.16 8.50% | -0.08 50.67% | -0.19 133.11% | -0.17 10.26% | ||
enterprise value | 249.09M - | 240.22M 3.56% | 217.84M 9.32% | 228.98M 5.11% | 151.75M 33.73% | 568.26M 274.48% | 1.71B 201.01% | 4.11B 140.36% | 3.56B 13.37% | 3.45B 3.20% | -258.15M 107.49% | |
enterprise value over ebitda | -61.91 - | -21.28 65.63% | 34.04 259.97% | -8.39 124.65% | -3.00 64.27% | -4.54 51.50% | -6.05 33.11% | -19.63 224.61% | -6.68 65.96% | -5.90 11.73% | 0.47 107.99% | |
ev to operating cash flow | -72.31 - | -24.15 66.60% | -11.55 52.16% | -8.81 23.78% | -3.26 63.02% | -4.33 32.95% | -8.10 87.10% | -25.62 216.21% | -6.32 75.31% | -6.71 6.11% | 0.43 106.47% | |
ev to sales | 16.40 - | 53.50 226.20% | 45.71 14.57% | -0.70 101.54% | ||||||||
free cash flow per share | -0.19 - | -0.55 189.34% | -1.04 89.19% | -1.44 37.90% | -3.36 133.73% | -2.41 28.18% | -3.42 41.75% | -2.21 35.46% | -6.68 202.79% | -6.86 2.57% | ||
free cash flow yield | -0.01 - | -0.04 189.34% | -0.07 89.19% | -0.10 37.90% | -0.15 51.12% | -0.18 18.16% | -0.11 38.94% | -0.04 65.45% | -0.14 266.32% | -0.13 6.22% | ||
graham net net | 0.24 - | 0.72 201.16% | 1.81 153.12% | 1.17 35.30% | 10.27 775.47% | 2.46 76.07% | -0.05 101.98% | 1.62 3,423.36% | 0.39 75.72% | 0.13 65.77% | ||
graham number | 1.11 - | 3.13 182.19% | 10.57 237.69% | 6.66 37.02% | 29.81 347.51% | 12.49 58.09% | 7.85 37.17% | 16.76 113.54% | 21.64 29.08% | 21.01 2.91% | ||
income quality | 0.87 - | 0.92 6.04% | 0.41 56.03% | 0.96 136.49% | 0.91 4.71% | 1.03 12.68% | 0.69 32.68% | 0.47 32.84% | 0.75 62.14% | 0.79 4.41% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 523.83 - | -50.91 109.72% | -54.50 7.06% | -7.14 86.90% | -40.50 467.31% | -18.23 55.00% | 18.51 201.54% | |||||
interest debt per share | 1.90 - | 0.54 71.33% | 2.61 380.04% | 5.42 107.94% | 2.65 51.20% | 1.93 26.95% | ||||||
inventory turnover | 0.32 - | 0.07 79.41% | 0.40 507.97% | |||||||||
invested capital | 0.18 - | 0.17 5.18% | 4.59 2,630.65% | 1.85 59.75% | 1.06 42.70% | 0.66 37.30% | 0.48 27.92% | |||||
market cap | 253.84M - | 253.84M 0% | 253.84M 0% | 253.84M 0% | 301.00M 18.58% | 717.48M 138.37% | 1.91B 165.57% | 4.30B 125.63% | 3.99B 7.16% | 3.89B 2.62% | ||
net current asset value | 4.51M - | 13.17M 191.70% | 34.84M 164.65% | 23.73M 31.90% | 148.83M 527.17% | 159.88M 7.43% | 18.08M 88.69% | 161.18M 791.51% | 140.94M 12.55% | 129.18M 8.35% | 172.12M 33.24% | |
net debt to ebitda | 1.18 - | 1.21 2.05% | -5.63 566.20% | 0.91 116.20% | 2.95 223.65% | 1.19 59.55% | 0.69 42.23% | 0.90 30.27% | 0.81 10.16% | 0.75 6.88% | 0.47 37.23% | |
net income per share | -0.22 - | -0.60 172.33% | -2.57 331.16% | -1.50 41.69% | -3.68 145.28% | -2.34 36.26% | -4.98 112.40% | -4.59 7.84% | -8.84 92.68% | -8.68 1.86% | ||
operating cash flow per share | -0.19 - | -0.55 188.76% | -1.04 89.57% | -1.44 37.90% | -3.36 133.73% | -2.41 28.18% | -3.39 40.63% | -2.14 37.07% | -6.67 212.40% | -6.84 2.47% | ||
payables turnover | 13.86 - | 12.47 9.99% | 34.45 176.16% | 2.96 91.42% | 0.31 89.59% | 0.15 50.92% | 1.56 933.33% | |||||
receivables turnover | 6.59 - | 9.76 48.15% | 1.77 81.82% | |||||||||
research and ddevelopement to revenue | 1.20 - | 6.32 428.41% | 5.13 18.80% | 0.97 81.16% | ||||||||
return on tangible assets | -0.76 - | -0.75 1.02% | -1.22 61.57% | -0.99 18.85% | -0.28 71.68% | -0.63 123.69% | -0.80 27.06% | -0.36 54.89% | -0.85 135.75% | -0.86 1.35% | -0.67 21.87% | |
revenue per share | 3.33 - | 0.79 76.36% | 1.00 27.27% | |||||||||
roe | -0.88 - | -0.82 6.87% | -1.33 63.02% | -1.14 14.28% | -0.34 69.96% | -0.79 131.29% | -9.05 1,042.71% | -1.69 81.37% | -3.76 122.84% | -3.84 2.19% | -2.72 29.21% | |
roic | -0.89 - | -0.82 7.93% | -0.57 30.28% | -1.15 100.48% | -0.29 74.62% | -0.68 132.86% | -1.42 110.09% | -0.36 74.89% | -1.25 249.04% | -1.97 57.70% | -1.91 2.84% | |
sales general and administrative to revenue | 0.56 - | 2.66 377.50% | 3.67 38.38% | 1.37 62.79% | ||||||||
shareholders equity per share | 0.25 - | 0.73 192.42% | 1.93 164.48% | 1.32 31.97% | 10.74 716.49% | 2.96 72.44% | 0.55 81.41% | 2.72 394.77% | 2.35 13.53% | 2.26 3.96% | ||
stock based compensation to revenue | 0.18 - | 1.06 486.43% | 1.21 13.75% | |||||||||
tangible asset value | 4.52M - | 13.22M 192.42% | 34.98M 164.48% | 23.79M 31.97% | 148.94M 525.96% | 160.97M 8.08% | 34.23M 78.74% | 204.56M 497.60% | 198.66M 2.88% | 169.87M 14.49% | 194.52M 14.51% | |
tangible book value per share | 0.25 - | 0.73 192.42% | 1.93 164.48% | 1.32 31.97% | 10.74 716.49% | 2.96 72.44% | 0.55 81.41% | 2.72 394.77% | 2.35 13.53% | 2.26 3.96% | ||
working capital | 4.51M - | 13.17M 191.70% | 34.84M 164.65% | 23.73M 31.90% | 175.46M 639.41% | 185.41M 5.67% | 307.34M 65.76% | 788.87M 156.67% | 692.20M 12.25% | 551.91M 20.27% | 518.74M 6.01% |
All numbers in USD (except ratios and percentages)